See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Trade War
Artificial Intelligence
Donald Trump
Social Media
Stock Markets
Trade
European Union
US Economy
Natural Disasters
Taxes
Baseball
Published • loading... • Updated

New form of SMA treatment Evrysdi may give patients 'freedom'

Summary by SMA News Today
A tablet formulation of Evrysdi (risdiplam) for spinal muscular atrophy (SMA) recently approved in the U.S. is designed to give patients a new option, a Genentech official said. “Evrysdi is the only oral, non-invasive disease-modifying SMA treatment, and the new tablet formulation may provide greater freedom and independence for people with SMA, thanks to simplified dose administration,” said Gregory Rippon, MD, vice president and chief medical …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Cure SMACure SMA

Check Out Cure SMA’s 2024 Annual State of SMA Report

Check Out Cure SMA’s 2024 Annual State of SMA Report Cure SMA is pleased to announce the launch of our next State of SMA report, showcasing data through 2024. The annual data report highlights data from Cure SMA’s three databases: a patient-reported database with data from over 11,000 impacted individuals worldwide that also incorporates longitudinal data from our annual Community Update Survey; the SMA Clinical Data Registry (CDR) that contains…

Read Full Article
SMA News TodaySMA News Today

New form of SMA treatment Evrysdi may give patients 'freedom'

A tablet formulation of Evrysdi (risdiplam) for spinal muscular atrophy (SMA) recently approved in the U.S. is designed to give patients a new option, a Genentech official said. “Evrysdi is the only oral, non-invasive disease-modifying SMA treatment, and the new tablet formulation may provide greater freedom and independence for people with SMA, thanks to simplified dose administration,” said Gregory Rippon, MD, vice president and chief medical …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

SMA News Today broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal